SeniorWISE: Improving Everyday Memory in At-Risk Elderly
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to determine whether classes on memory training will help older adults to improve or maintain their daily activities.
Condition or disease
Procedure: Memory Training
Volunteer participants will be randomly assigned to experimental (memory training) and comparison (health promotion) groups. Both groups will learn strategies for successful aging. Participants will be in the study for 27 months and will be interviewed on five occasions for 3 hours per interview. The classroom-based intervention is an 8-session, 1 1/2 hour course designed to teach older adults the use of strategies to improve everyday memory. Strategically-placed booster sessions will be provided to subjects within 3 months following the last class session.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
65 Years and older (Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Reside in Austin, Texas or Travis County
African, Caucasian, or Hispanic heritage
Fluent in reading and speaking English
Mini Mental Exam scores of 23-30
Pass executive function test
Adequate hearing and vision to enable participation in classroom learning
Free of Alzheimer's disease or other conditions (e.g., certain cancers) likely to result in mortality before study completion
Score less than 23 on MMSE
Fail the executive function tests
Severe sensory losses, hearing or vision, that would prohibit testing or participation
self-report a diagnosis of Alzheimer's disease or other conditions (e.g., certain cancers) likely to result in mortality before study completion